|
Apr 3
|
Guardant Health and Bayshore HealthCare Partner to Expand Access to Advanced Precision Oncology Testing in Canada
|
|
Apr 1
|
3 Small-Cap Stocks in the Doghouse
|
|
Apr 1
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
|
|
Mar 25
|
Guardant Health’s Shield Blood Test Now Covered for VA Community Care Beneficiaries
|
|
Mar 11
|
Guardant Health Receives ADLT Status From CMS for Shield Blood Test
|
|
Feb 24
|
Guardant accuses Natera of poaching employees, stealing trade secrets
|
|
Feb 22
|
Guardant Health price target raised to $56 from $42 at TD Cowen
|
|
Feb 22
|
Guardant Health Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Feb 21
|
These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50
|
|
Feb 21
|
What's Going On With Cancer Diagnostic Firm Guardant Health On Friday?
|
|
Feb 21
|
Guardant Health Inc (GH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
|
|
Feb 20
|
Guardant Health (GH) Reports Q4 Earnings: What Key Metrics Have to Say
|
|
Feb 20
|
Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates
|
|
Feb 20
|
Guardant Health: Q4 Earnings Snapshot
|
|
Feb 20
|
Guardant Health Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook
|
|
Feb 19
|
Why Guardant Health, Inc. (GH) is the Best Performing Healthcare Stock So Far in 2025
|
|
Feb 17
|
Will Fate Therapeutics (FATE) Report Negative Q4 Earnings? What You Should Know
|
|
Feb 17
|
Exploring Analyst Estimates for Guardant Health (GH) Q4 Earnings, Beyond Revenue and EPS
|
|
Feb 13
|
Guardant Health (GH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Feb 11
|
Here's Why Guardant Health (GH) Is a Great 'Buy the Bottom' Stock Now
|